Oxcarbazepine add‐on for drug‐resistant focal epilepsy https://t.co/aaf1ipBvzl Systematic review from @CochraneEpileps includes 6 studies with 1,593 people with a diagnosis of drug‐resistant focal #epilepsy. https://t.co/QvN4Z6TWrN
RT @CochraneLibrary: Oxcarbazepine add‐on for drug‐resistant focal epilepsy https://t.co/UUtDmv0f3G Systematic review from @CochraneEpileps…
Oxcarbazepine add‐on for drug‐resistant focal epilepsy https://t.co/UUtDmv0f3G Systematic review from @CochraneEpileps includes 6 studies with 1,593 people with a diagnosis of drug‐resistant focal #epilepsy.
RT @epilepsy_liv: New LERG publication on use of Oxcarbazepine as an add on therapy for refractory #epilepsy: “Overall, we are unsure of th…
RT @epilepsy_liv: New LERG publication on use of Oxcarbazepine as an add on therapy for refractory #epilepsy: “Overall, we are unsure of th…
RT @epilepsy_liv: New LERG publication on use of Oxcarbazepine as an add on therapy for refractory #epilepsy: “Overall, we are unsure of th…
New LERG publication on use of Oxcarbazepine as an add on therapy for refractory #epilepsy: “Overall, we are unsure of the true efficacy of oxcarbazepine, but have concerns about its tolerability.” https://t.co/FYxuqrp8yD https://t.co/2XdFvopynN